Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium - PubMed (original) (raw)

Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium

L A Holladay et al. Proc Natl Acad Sci U S A. 1976 Apr.

Abstract

Somatostatin is a hypothalamic tetradeca peptide that inhibits the release of growth hormone insulin, and glucagon. The circular dichroism spectrum is characterized by negative extrema at 238 nm and 270 nm, and a positive extremum at 225 nm. The far ultraviolet circular dichroism spectrum is consistent with the presence of ordered secondary structure such as beta-structure, but not alpha-helix. Sedimentation equilibrium results demonstrate that somatostatin exists in its monomeric form (i.e., a molecular weight of 1610 +/- 36 was obtained) and, thus, the structure must arise from intramolecular interactions. The diffusion constant of somatostatin was estimated to be 1.66 X 10(-6) cm2/sec. These data are consistent with an ellipsoidal rather than a spherical shape. The magnitude of the ellipticity at both 225 nm and 238 nm is quite dependent on guanidinium hydrochloride concentration; the midpoint occurs at about 3 M and the transition is cooperative-like. These data strongly suggest that somatostatin has a stable conformation in aqueous solution. A model, consistent with the results of the physicochemical studies and with semi-empirical rules for secondary structure formation, is proposed for somatostatin. The proposed structure consists of a hairpin loop with several residues in an antiparallel beta-pleated sheet, is somewhat elongated, and contains a hydrophobic domain at one end and a hydrophilic domain at the other end.

PubMed Disclaimer

Cited by

Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease.
Rol Á, Todorovski T, Martin-Malpartida P, Escolà A, Gonzalez-Rey E, Aragón E, Verdaguer X, Vallès-Miret M, Farrera-Sinfreu J, Puig E, Fernández-Carneado J, Ponsati B, Delgado M, Riera A, Macias MJ. Rol Á, et al. Nat Commun. 2021 Mar 25;12(1):1869. doi: 10.1038/s41467-021-22076-5. Nat Commun. 2021. PMID: 33767180 Free PMC article.
Temperature-induced conformational changes in prosomatostatin-II: implications for processing.
Mitra J, Tang X, Almo SC, Shields D. Mitra J, et al. Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):275-82. doi: 10.1042/bj3340275. Biochem J. 1998. PMID: 9693130 Free PMC article.
GABAC receptor sensitivity is modulated by interaction with MAP1B.
Billups D, Hanley JG, Orme M, Attwell D, Moss SJ. Billups D, et al. J Neurosci. 2000 Dec 1;20(23):8643-50. doi: 10.1523/JNEUROSCI.20-23-08643.2000. J Neurosci. 2000. PMID: 11102469 Free PMC article.
Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
Brown MP, Coy DH, Gomez-Pan A, Hirst BH, Hunter M, Meyers C, Reed JD, Schally AV, Shaw B. Brown MP, et al. J Physiol. 1978 Apr;277:1-14. doi: 10.1113/jphysiol.1978.sp012256. J Physiol. 1978. PMID: 349135 Free PMC article.
Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.
Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS, Bern HA. Pearson D, et al. Proc Natl Acad Sci U S A. 1980 Aug;77(8):5021-4. doi: 10.1073/pnas.77.8.5021. Proc Natl Acad Sci U S A. 1980. PMID: 6107911 Free PMC article.

References

1. J Am Chem Soc. 1974 May 1;96(9):2986-92 - PubMed
1. Proc Natl Acad Sci U S A. 1973 Mar;70(3):684-8 - PubMed
1. Biopolymers. 1976 Jan;15(1):43-59 - PubMed
1. Biochemistry. 1974 Apr 9;13(8):1653-61 - PubMed
1. Science. 1973 Jan 5;179(4068):77-9 - PubMed

Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium - PubMed (original) (raw)